{
    "title": "German COVID-19 vaccine developer CureVac files for U.S. IPO",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8557843/German-COVID-19-vaccine-developer-CureVac-files-U-S-IPO.html",
    "date": "2020-07-24",
    "keywords": [
        "curevac",
        "stake",
        "government",
        "company",
        "ipo",
        "vaccine",
        "covid19",
        "year",
        "approach",
        "frankfurtbengaluru",
        "july",
        "biotech",
        "friday",
        "offering",
        "corp",
        "cofounder",
        "bill",
        "foundation",
        "shareholder",
        "study",
        "trial",
        "quarter",
        "approval",
        "middle",
        "filing",
        "time",
        "drugmaker",
        "glaxosmithkline",
        "plc",
        "qatar",
        "investment",
        "authority",
        "support",
        "june",
        "aid",
        "development",
        "companys",
        "program",
        "software",
        "firm",
        "dietmar",
        "hopp",
        "pioneer",
        "messenger",
        "biontech",
        "partner",
        "pfizer",
        "moderna",
        "therapy",
        "bank",
        "credit",
        "suisse",
        "tom",
        "huebner",
        "munich",
        "ankur",
        "banerjee",
        "bengaluru",
        "editing",
        "ramakrishnan"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}